Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Kidney Disease, Chronic
  • Kidney Diseases
  • Kidney Failure
Type
Observational
Design
Observational Model: CohortTime Perspective: Prospective

Participation Requirements

Age
Younger than 125 years
Gender
Both males and females

Description

The National Institutes of Health (NIH)-sponsored collaborative APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) is charged with prospectively assessing the effects of renal-risk variants (RRVs) in the apolipoprotein L1 gene (APOL1) on outcomes for kidneys from donors with recent Afr...

The National Institutes of Health (NIH)-sponsored collaborative APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) is charged with prospectively assessing the effects of renal-risk variants (RRVs) in the apolipoprotein L1 gene (APOL1) on outcomes for kidneys from donors with recent African ancestry and the recipients of their kidneys, after deceased- and living-donor renal transplantation. For the purposes of APOLLO, recent African ancestry is defined as individuals with similar genetic make-up to those currently residing in Africa. APOLLO will also study the impact of APOL1 RRVs on the health of living kidney donors with recent African ancestry.

Tracking Information

NCT #
NCT03615235
Collaborators
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • National Institute on Minority Health and Health Disparities (NIMHD)
  • National Institute of Allergy and Infectious Diseases (NIAID)
Investigators
Principal Investigator: Barry I. Freedman, MD Wake Forest University Health Sciences Principal Investigator: David M. Reboussin, PhD Wake Forest University Health Sciences Study Director: Paul L. Kimmel, MD Natl Institute of Diabetes, Digestive & Kidney Diseases Study Chair: Marva Moxey-Mims, MD Children's Natl Health System; George Washington Univ Sch of Med and Health Serv